Advertisement

Topics

Search Results for "Drug Class Action Settlement"

15:50 EDT 29th August 2016 | BioPortfolio

Matching Channels

Duocarmycin analogs

Antibody-drug conjugates are designed to combine the specificity of antibodies directed against tumor-associated targets with potent cytotoxity. Upon internalization of the ADC, the antibody-bound c...

CMV Antisense Drug

Bcl-2 Antisense Drug

Tuberculosis Vaccines and Therapeutics

The WHO estimates that the largest number of new tuberculosis (TB) cases in 2008 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated inci...

Adverse drug effects

Matching News

Zwerling, Schachter & Zwerling, LLP Announce the Partial Settlement of a Class Action...

A partial Settlement has been reached in a class action lawsuit involving the antibiotic drug Cipro. The lawsuit claims that Bayer Corporation, Barr Laboratories, Inc., Hoechst Marion Roussel, Inc., W...

Miller Schirger and Stueve Siegel Hanson Announce Major Class Action Settlement Approved over Alleged Life Insurance Policy Overcharges

Allen County, IN (PRWEB) March 23, 2016 Miller Schirger LLC and Stueve Siegel Hanson LLP, law firms based in Kansas City, Mo., annou...

Calif. provider settles class action suit for $7.5M in wake of data breach

St. Joseph Health has finalized a class-action lawsuit settlement for a 2012 data breach that affected 31,000 patients.

Zwerling, Schachter & Zwerling, LLP Announce the Partial Settlement of a Class Action Lawsuit Involving the Antibiotic Drug Cipro

SEATTLE, Aug. 22, 2016 /PRNewswire/ -- If You Paid for the Antibiotic Cipro in CaliforniaYou Could Get Money from a Class Action Settlement A partial Settlement has been reached in a class action l...

St Jude in $39.25 mln shareholder settlement over heart devices

July 8 (Reuters) - St. Jude Medical Inc has reached a $39.25 million class action settlement with shareholders to resolve claims it downplayed the possible dangers associated with a product used to co...

WEN Class Action Headed For Potential $26M Settlement In California

Individuals with documented hair loss or other injuries attributed to use of WEN Cleansing Conditioners could be compensated with payments up to $20,000 apiece under a proposed settlement expected to ...

Class Action Continues Against Zantrex-3 Maker After Rejected Settlement

The ruling in US District Court for the Eastern New York District notes a Supreme Court decision in January in a separate case that also focused on settlement offers rejected by plaintiffs in civil li...

Pharmalot, Pharmalittle: Court revives class action against Pfizer

A federal appeals court revived a securities class action against Pfizer that accused the drug maker of hiding heart risks of the Celebrex and Bextra painkillers.

Matching PubMed Articles

The new antitumor drug ABTL0812 inhibits the Akt/mTORC1 axis by upregulating Tribbles-3 pseudokinase.

ABTL0812 is a novel first-in-class, small molecule which showed anti-proliferative effect on tumor cells on phenotypic assays. Here we describe the mechanism of action this antitumor drug, which is cu...

Hit-to-Lead Optimisation of a Novel Class of Potent, Broad-Spectrum Trypanosomacides.

The parasitic trypanosomes Trypanosoma bruce and T. cruzi are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease. Drugs currently availab...

Medibots: Dual-Action Biogenic Microdaggers for Single-Cell Surgery and Drug Release.

An innovative concept for the fabrication of dual-action microrobots capable of performing single-cell microsurgery along with site-directed drug delivery feature is presented. These multi-action plan...

Settlement-Size Scaling among Prehistoric Hunter-Gatherer Settlement Systems in the New World.

Settlement size predicts extreme variation in the rates and magnitudes of many social and ecological processes in human societies. Yet, the factors that drive human settlement-size variation remain po...

Non-toxic metal-cyclam complexes, a new class of compounds with potency against drug-resistant Mycobacterium tuberculosis.

Tuberculosis (TB) accounted for 1.5 million deaths in 2014 and new classes of anti-TB drugs are required. We report a class of functionalized 1,8-disubstituted cyclam derivatives that display low micr...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement